Sikora, Andrew G <br/><br/>
Targeted inhibition of inducible nitric oxide synthase inhibits growth of human melanoma in vivo and synergizes with chemotherapy.  [electronic resource] 

 -  Clinical cancer research : an official journal of the American Association for Cancer Research  Mar 2010 
 - 1834-44 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1557-3265 
<br/><br/><label>Standard No.: </label>10.1158/1078-0432.CCR-09-3123  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents--therapeutic use<br/>Apoptosis<br/>Blotting, Western<br/>Cells, Cultured<br/>Cisplatin--therapeutic use<br/>Drug Synergism<br/>Endothelium, Vascular--cytology<br/>Enzyme Inhibitors--pharmacology<br/>Female<br/>Humans<br/>Immunoenzyme Techniques<br/>Lysine--analogs & derivatives<br/>Melanoma--enzymology<br/>Mice<br/>Mice, Inbred C57BL<br/>Mice, Inbred NOD<br/>Mice, SCID<br/>Nitric Oxide Synthase Type II--antagonists & inhibitors<br/>Xenograft Model Antitumor Assays